{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T16:10:57Z","timestamp":1768147857119,"version":"3.49.0"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The global shortage of RhD immune globulin, formally acknowledged by the Food and Drug Administration in 2023, is ongoing but has improved in recent months. In response, the American College of Obstetricians and Gynecologists (ACOG) issued guidance in March 2024 on alternative strategies to conserve RhD immune globulin supplies. Our objective is to evaluate strategies for optimizing RhD immune globulin use in pregnancy amidst a global shortage.<\/jats:p><jats:p>This clinical opinion reviews guidance on strategies to conserve RhD immune globulin. These include targeted administration based on non-invasive fetal RhD genotyping using cell-free DNA (cfDNA), the use of alternative RhD immune globulin products, and selective withholding of prophylaxis in early pregnancy loss under 12 weeks' gestation. ACOG guidance on the administration of RhD immune globulin in pregnancy differs from many countries worldwide, as well as the World Health Organization and the American Society of Family Planning.<\/jats:p><jats:p>Targeted administration and the use of non-invasive cell-free DNA (cfDNA) testing for fetal RhD status have shown promising accuracy and reliability in studies across multiple countries, leading to reduced unnecessary prophylaxis and potential cost savings. Additionally, withholding RhD immune globulin in select early pregnancy losses could further conserve resources without increasing alloimmunization risk.<\/jats:p><jats:p>This review underscores the need for evidence-based approaches to manage limited RhD immune globulin supplies effectively and suggests that targeted prophylaxis could benefit both patient outcomes and healthcare resource allocation in the face of global shortages.<\/jats:p>","DOI":"10.1055\/a-2550-5130","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:05:16Z","timestamp":1741115116000},"page":"1928-1934","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing RhD Immune Globulin Use in Pregnancy"],"prefix":"10.1055","volume":"42","author":[{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"El-Kassis","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Saade","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-4061","authenticated-orcid":false,"given":"Rebecca","family":"Horgan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Macon and Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, Virginia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235807","volume-title":"Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children","author":"V Pegoraro","year":"2020"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000083027","article-title":"Distribution of rhesus blood group system in the French basques: a reappraisal using the allele-specific primers PCR method","volume":"58","author":"M Touinssi","year":"2004","journal-title":"Hum Hered"},{"key":"ref6","volume-title":"The Rh blood group, Chapter 7","author":"L Dean","year":"2005"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Practice bulletin no. 181: prevention of Rh D alloimmunization","volume":"130","author":"Practice Bulletin No","year":"2017","journal-title":"Obstet Gynecol"},{"key":"ref8","volume-title":"Rho(D) Immune Globulin","author":"A L Yoham","year":"2024"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1423-0410.2012.01602.x","article-title":"Study of compliance with a new, targeted antenatal D immunization prevention programme in Denmark","volume":"103","author":"M B Damkjaer","year":"2012","journal-title":"Vox Sang"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/1471-0528.13055","article-title":"Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS","volume":"122","author":"P W Soothill","year":"2015","journal-title":"BJOG"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1537-2995.2007.01533.x","article-title":"Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium","volume":"48","author":"J M Minon","year":"2008","journal-title":"Transfusion"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/vox.13348","article-title":"Single-exon approach to non-invasive fetal RHD screening in early pregnancy: an update after 10\u2009years' experience","volume":"117","author":"M Uzunel","year":"2022","journal-title":"Vox Sang"},{"issue":"06","key":"ref13","first-page":"514","article-title":"Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis","volume":"16","author":"S Manfroi","year":"2018","journal-title":"Blood Transfus"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/AOG.0000000000005794","article-title":"Clinical validation of a prenatal cell-free dna screening test for fetal RHD in a large U.S. cohort","volume":"145","author":"M Gilstrop Thompson","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1038\/s41598-023-39283-3","article-title":"Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fya antigens","volume":"13","author":"B Alford","year":"2023","journal-title":"Sci Rep"},{"issue":"18","key":"ref16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3109\/14767058.2014.882306","article-title":"Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis","volume":"27","author":"Y J Zhu","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"P G Scheffer","year":"2011","journal-title":"BJOG"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/1471-0528.14050","article-title":"The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis","volume":"124","author":"F L Mackie","year":"2017","journal-title":"BJOG"},{"issue":"13","key":"ref19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22130","article-title":"High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation","volume":"22","author":"P Saramago","year":"2018","journal-title":"Health Technol Assess"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"i5789","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"M de Haas","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/aogs.13191","article-title":"Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland","volume":"96","author":"K Haimila","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13104-016-2002-x","article-title":"Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus","volume":"9","author":"T Papasavva","year":"2016","journal-title":"BMC Res Notes"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/pd.5176","article-title":"Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: a cost-effectiveness analysis","volume":"37","author":"L G Gordon","year":"2017","journal-title":"Prenat Diagn"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/AOG.0b013e31829f8814","article-title":"Costs and clinical outcomes of noninvasive fetal RhD typing for targeted prophylaxis","volume":"122","author":"A F Hawk","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pd.5415","article-title":"Cell free fetal DNA to triage antenatal rhesus immune globulin: Is it really cost-effective in the United States?","volume":"39","author":"K J Moise Jr","year":"2019","journal-title":"Prenat Diagn"},{"issue":"05","key":"ref28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/trf.16826","article-title":"Cost-effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies","volume":"62","author":"O Gajic-Veljanoski","year":"2022","journal-title":"Transfusion"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/AOG.0000000000001213","article-title":"ACOG committee opinion no. 649: racial and ethnic disparities in obstetrics and gynecology","volume":"126","author":"ACOG Committee Opinion No","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/j.semperi.2017.04.008","article-title":"Exploring the social determinants of racial\/ethnic disparities in prenatal care utilization and maternal outcome","volume":"41","author":"A Gadson","year":"2017","journal-title":"Semin Perinatol"},{"issue":"11","key":"ref32","first-page":"1121","article-title":"WinRho: Rh immune globulin prepared by ion exchange for intravenous use","volume":"123","author":"J M Bowman","year":"1980","journal-title":"Can Med Assoc J"},{"issue":"S 01","key":"ref33","first-page":"9","article-title":"Safety profile of WinRho anti-D","volume":"35","author":"F Hong","year":"1998","journal-title":"Semin Hematol"},{"key":"ref34","doi-asserted-by":"publisher","volume-title":"Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy","author":"C I Okwundu","DOI":"10.1002\/14651858.CD007885.pub2"},{"issue":"05","key":"ref35","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG practice bulletin no. 200: early pregnancy loss","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Gynecology","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2024.02.288","article-title":"Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion at less than 12 weeks of gestation","volume":"230","author":"M Prabhu","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.07.002","article-title":"Society of Family Planning committee consensus on Rh testing in early pregnancy","volume":"114","author":"S Horvath","year":"2022","journal-title":"Contraception"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2020.02.011","article-title":"The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization","volume":"102","author":"S Horvath","year":"2020","journal-title":"Contraception"},{"issue":"S 18","key":"ref39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"105","author":"S J Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"100001","DOI":"10.1016\/j.conx.2018.100001","article-title":"Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and the Netherlands","volume":"1","author":"E R Wiebe","year":"2019","journal-title":"Contracept X"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2550-5130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:56Z","timestamp":1759271936000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2550-5130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":34,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,9,30]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2550-5130","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,4]]},"published":{"date-parts":[[2025,3,4]]}}}